400 related articles for article (PubMed ID: 24942631)
1. Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial.
Rintoul RC; Ritchie AJ; Edwards JG; Waller DA; Coonar AS; Bennett M; Lovato E; Hughes V; Fox-Rushby JA; Sharples LD;
Lancet; 2014 Sep; 384(9948):1118-27. PubMed ID: 24942631
[TBL] [Abstract][Full Text] [Related]
2. The MesoVATS trial: is there a future for video-assisted thoracoscopic surgery partial pleurectomy?
Rintoul RC
Future Oncol; 2015; 11(24 Suppl):15-7. PubMed ID: 26638917
[TBL] [Abstract][Full Text] [Related]
3. Persistent lung expansion after pleural talc poudrage in non-surgically resected malignant pleural mesothelioma.
Rena O; Boldorini R; Papalia E; Mezzapelle R; Baietto G; Roncon A; Casadio C
Ann Thorac Surg; 2015 Apr; 99(4):1177-83. PubMed ID: 25669666
[TBL] [Abstract][Full Text] [Related]
4. Video-assisted biopsy and talc pleurodesis for malignant pleural mesothelioma.
Maat A; Abdullah S; Schouten G; Cornelissen R; Bogers A; Mahtab E
Multimed Man Cardiothorac Surg; 2020 Jul; 2020():. PubMed ID: 32633902
[TBL] [Abstract][Full Text] [Related]
5. Surgical resection of mesothelioma: an evidence-free practice.
Lee YC
Lancet; 2014 Sep; 384(9948):1080-1. PubMed ID: 24942632
[No Abstract] [Full Text] [Related]
6. Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion.
Fitzgerald DB; Sidhu C; Budgeon C; Tan AL; Read CA; Kwan BCH; Smith NA; Fysh ET; Muruganandan S; Saghaie T; Shrestha R; Badiei A; Nguyen P; Burke A; Goddard J; Windsor M; McDonald J; Wright G; Czarnecka K; Sivakumar P; Yasufuku K; Feller-Kopman DJ; Maskell NA; Murray K; Lee YCG
Trials; 2022 Jun; 23(1):530. PubMed ID: 35761341
[TBL] [Abstract][Full Text] [Related]
7. MesoTRAP: a feasibility study that includes a pilot clinical trial comparing video-assisted thoracoscopic partial pleurectomy decortication with indwelling pleural catheter in patients with trapped lung due to malignant pleural mesothelioma designed to address recruitment and randomisation uncertainties and sample size requirements for a phase III trial.
Matthews C; Freeman C; Sharples LD; Fox-Rushby J; Tod A; Maskell NA; Edwards JG; Coonar AS; Sivasothy P; Hughes V; Rahman NM; Waller DA; Rintoul RC
BMJ Open Respir Res; 2019; 6(1):e000368. PubMed ID: 30687504
[TBL] [Abstract][Full Text] [Related]
8. Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.
Thomas R; Fysh ETH; Smith NA; Lee P; Kwan BCH; Yap E; Horwood FC; Piccolo F; Lam DCL; Garske LA; Shrestha R; Kosky C; Read CA; Murray K; Lee YCG
JAMA; 2017 Nov; 318(19):1903-1912. PubMed ID: 29164255
[TBL] [Abstract][Full Text] [Related]
9. Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial.
Muruganandan S; Azzopardi M; Fitzgerald DB; Shrestha R; Kwan BCH; Lam DCL; De Chaneet CC; Rashid Ali MRS; Yap E; Tobin CL; Garske LA; Nguyen PT; Stanley C; Popowicz ND; Kosky C; Thomas R; Read CA; Budgeon CA; Feller-Kopman D; Maskell NA; Murray K; Lee YCG
Lancet Respir Med; 2018 Sep; 6(9):671-680. PubMed ID: 30037711
[TBL] [Abstract][Full Text] [Related]
10. Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial.
Psallidas I; Hassan M; Yousuf A; Duncan T; Khan SL; Blyth KG; Evison M; Corcoran JP; Barnes S; Reddy R; Bonta PI; Bhatnagar R; Kagithala G; Dobson M; Knight R; Dutton SJ; Luengo-Fernandez R; Hedley E; Piotrowska H; Brown L; Asa'ari KAM; Mercer RM; Asciak R; Bedawi EO; Hallifax RJ; Slade M; Benamore R; Edey A; Miller RF; Maskell NA; Rahman NM
Lancet Respir Med; 2022 Feb; 10(2):139-148. PubMed ID: 34634246
[TBL] [Abstract][Full Text] [Related]
11. Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT.
Bhatnagar R; Luengo-Fernandez R; Kahan BC; Rahman NM; Miller RF; Maskell NA
Health Technol Assess; 2020 Jun; 24(26):1-90. PubMed ID: 32525474
[TBL] [Abstract][Full Text] [Related]
12. Video-assisted cervical thoracoscopy: a novel approach for diagnosis, staging and pleurodesis of malignant pleural mesothelioma.
Chamberlain MH; Fareed K; Nakas A; Martin-Ucar AE; Waller DA
Eur J Cardiothorac Surg; 2008 Jul; 34(1):200-3. PubMed ID: 18450462
[TBL] [Abstract][Full Text] [Related]
13. Prolonged survival after talc poudrage for malignant pleural mesothelioma: case series.
Aelony Y; Yao JF
Respirology; 2005 Nov; 10(5):649-55. PubMed ID: 16268920
[TBL] [Abstract][Full Text] [Related]
14. Pleurodesis outcome in malignant pleural mesothelioma.
Fysh ET; Tan SK; Read CA; Lee F; McKenzie K; Olsen N; Weerasena I; Threlfall T; de Klerk N; Musk AW; Lee YC
Thorax; 2013 Jun; 68(6):594-6. PubMed ID: 23299964
[TBL] [Abstract][Full Text] [Related]
15. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in malignant pleural mesothelioma: role of talc pleurodesis.
Al-Alao BS; Parissis H; Rychlik IJ; Graham A; McGuigan J
Asian Cardiovasc Thorac Ann; 2012 Aug; 20(4):443-9. PubMed ID: 22879552
[TBL] [Abstract][Full Text] [Related]
17. Can serum inflammatory parameters estimate outcome of pleurodesis in mesothelioma?
Bilgin M; Hasdiraz L; Ozkaya M; Oguzkaya F
ANZ J Surg; 2007 Apr; 77(4):253-5. PubMed ID: 17388830
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
[TBL] [Abstract][Full Text] [Related]
19. Improved quality of life in patients with malignant pleural effusion following videoassisted thoracoscopic talc pleurodesis. Preliminary results.
Basso SM; Mazza F; Marzano B; Santeufemia DA; Chiara GB; Lumachi F
Anticancer Res; 2012 Nov; 32(11):5131-4. PubMed ID: 23155293
[TBL] [Abstract][Full Text] [Related]
20. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial.
Davies HE; Mishra EK; Kahan BC; Wrightson JM; Stanton AE; Guhan A; Davies CW; Grayez J; Harrison R; Prasad A; Crosthwaite N; Lee YC; Davies RJ; Miller RF; Rahman NM
JAMA; 2012 Jun; 307(22):2383-9. PubMed ID: 22610520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
